Objective-To investigate the defibrillator waiting time (time between
the recognition of atrial fibrillation and the actual shock) by studyi
ng paroxysmal atrial fibrillation episodes with RR intervals shorter t
han a certain limit (that is, episodes during which defibrillation sho
uld not be attempted). Methods-Long term 24 hour Holter recordings fi
om a digoxin v placebo crossover study in patients with paroxysmal atr
ial fibrillation were analysed. In all, 23 recordings with atrial fibr
illation episodes of at least 1000 ventricular cycles and with < 20% H
olter artefacts or noise were used (11 recorded on placebo and 12 on d
igoxin). For each recording, the mean (''mean waiting time'') and maxi
mum (''maximum waiting time'') duration of continuous sections of atri
al fibrillation episodes with all RR intervals shorter than a certain
threshold were evaluated, ranging the threshold from 400 to 1000 ms in
10 ms steps. For each threshold, the mean and maximum waiting times w
ere compared between recordings on placebo and on digoxin. Results-Bot
h the mean and maximum waiting times increased exponentially with incr
easing threshold. Practically acceptable mean waiting times less than
one minute were observed with thresholds below 600 ms. There were no s
ignificant differences in mean waiting times and maximum waiting times
between recordings on placebo and digoxin, and only a trend towards s
horter waiting times on digoxin. Conclusions-Introduction of a minimum
RR interval threshold required to deliver atrial defibrillation leads
to practically acceptable delays between atrial fibrillation recognit
ion and the actual shock. These delays are not prolonged by digoxin tr
eatment.